FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tobias Larsson

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Procedures

Enzyme-Linked Immunosorbent Assay

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Per-Anton Westerberg; Osten Ljunggren; Tobias Larsson; Jonas Wadström; Torbjörn Linde
Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy.
Tijana Krajisnik; Hannes Olauson; Majd A I Mirza; Per Hellman; Göran Akerström; Gunnar Westin; Tobias Larsson; Peyman Björklund
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Richard Marsell; M A I Mirza; Hans Mallmin; M Karlsson; Dan Mellström; Eric Orwoll; Claes Ohlsson; Kenneth B Jonsson; Osten Ljunggren; Tobias Larsson
Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tobias Larsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Per-Anton Westerberg; Osten Ljunggren; Tobias Larsson; Jonas Wadström; Torbjörn Linde
Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(12):4068-71.
2010: Tijana Krajisnik; Hannes Olauson; Majd A I Mirza; Per Hellman; Göran Akerström; Gunnar Westin; Tobias Larsson; Peyman Björklund
Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Kidney international 2010;78(10):1024-32.
2009: Richard Marsell; M A I Mirza; Hans Mallmin; M Karlsson; Dan Mellström; Eric Orwoll; Claes Ohlsson; Kenneth B Jonsson; Osten Ljunggren; Tobias Larsson
Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2009;20(7):1167-73.
2008: Peyman Björklund; Tijana Krajisnik; Göran Akerström; Gunnar Westin; Tobias Larsson
Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2008;93(10):4152-7.
2008: Karin Hollberg; Richard Marsell; Maria Norgård; Tobias Larsson; Kenneth B Jonsson; Göran Andersson
Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Bone 2008;42(6):1111-21.
2008: Hannes Olauson; Tijana Krajisnik; Charlotta Larsson; Bengt Lindberg; Tobias Larsson
A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome.
European journal of endocrinology / European Federation of Endocrine Societies 2008;158(6):929-34.
2008: Per-Anton Westerberg; Hannes Olauson; Göran Toss; Björn Wikström; Ollallo Morales; Torbjörn Linde; Kenneth Jonsson; Osten Ljunggren; Tobias Larsson
Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2008;14(3):362-7.
2008: Richard Marsell; Tijana Krajisnik; Hanna Göransson; Claes Ohlsson; Osten Ljunggren; Tobias Larsson; Kenneth B Jonsson
Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(3):827-33.
2008: Richard Marsell; Elin Grundberg; Tijana Krajisnik; Hans Mallmin; Magnus Karlsson; Dan Mellström; Eric Orwoll; Claes Ohlsson; Kenneth B Jonsson; Osten Ljunggren; Tobias Larsson
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
European journal of endocrinology / European Federation of Endocrine Societies 2008;158(1):125-9.
2007: Per-Anton Westerberg; Torbjörn Linde; Björn Wikström; Osten Ljunggren; Mats Stridsberg; Tobias Larsson
Regulation of fibroblast growth factor-23 in chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(11):3202-7.
2007: Tijana Krajisnik; Peyman Björklund; Richard Marsell; Osten Ljunggren; Göran Akerström; Kenneth B Jonsson; Gunnar Westin; Tobias Larsson
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
The Journal of endocrinology 2007;195(1):125-31.
2004: Tobias Larsson; Richard Marsell; Ernestina Schipani; Claes Ohlsson; Osten Ljunggren; Harriet S Tenenhouse; Harald Jüppner; Kenneth B Jonsson
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
Endocrinology 2004;145(7):3087-94.
2003: Tobias Larsson; Ulf Nisbeth; Osten Ljunggren; Harald Jüppner; Kenneth B Jonsson
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
Kidney international 2003;64(6):2272-9.
2003: Kenneth B Jonsson; Richard Zahradnik; Tobias Larsson; Kenneth E White; Toshitsugu Sugimoto; Yasuo Imanishi; Takehisa Yamamoto; Geeta Hampson; Hiroyuki Koshiyama; Osten Ljunggren; Koichi Oba; In Myung Yang; Akimitsu Miyauchi; Michael J Econs; Jeffrey Lavigne; Harald Jüppner
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
The New England journal of medicine 2003;348(17):1656-63.
2003: Tobias Larsson; Richard Zahradnik; Jeffrey Lavigne; Osten Ljunggren; Harald Jüppner; Kenneth B Jonsson
Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia.
European journal of endocrinology / European Federation of Endocrine Societies 2003;148(2):269-76.